Cas:145758-05-0 3,4-Difluorobenzenesulfonyl chloride manufacturer & supplier

We serve Chemical Name:3,4-Difluorobenzenesulfonyl chloride CAS:145758-05-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3,4-Difluorobenzenesulfonyl chloride

Chemical Name:3,4-Difluorobenzenesulfonyl chloride
CAS.NO:145758-05-0
Synonyms:Benzenesulfonyl chloride, 3,4-difluoro-;WSGR CF DF;MFCD00153120;3,4-Difluorobenzenesulfonyl chloride;3,4-Difluorobenzene-1-sulfonyl chloride
Molecular Formula:C6H3ClF2O2S
Molecular Weight:212.602
HS Code:2904909090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:258.1±20.0 °C at 760 mmHg
Density:1.6±0.1 g/cm3
Index of Refraction:1.516
PSA:42.52000
Exact Mass:211.951035
LogP:2.63

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 3265 8/PG 2
Packing Group:II


Contact us for information like Benzenesulfonyl chloride, 3,4-difluoro- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3,4-Difluorobenzene-1-sulfonyl chloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,WSGR CF DF Use and application,3,4-Difluorobenzenesulfonyl chloride technical grade,usp/ep/jp grade.


Related News: Pharmaceutical intermediates and APIs belong to the fine chemical industry. 3,4-Difluorobenzenesulfonyl chloride manufacturer There are however certain APIs that are unknown and so require additional substances that work in conjunction with the API to produce the required effect. 3,4-Difluorobenzenesulfonyl chloride supplier An active pharmaceutical ingredient (API) is a substance, or a mixture of ingredients, combined in the manufacture of a pharmaceutical or drug. 3,4-Difluorobenzenesulfonyl chloride vendor Large pharmaceutical companies are investing a disproportionately large amount of annual revenue in research and development (R&D), according to GlobalData��s Company Financials database. 3,4-Difluorobenzenesulfonyl chloride factory Large pharmaceutical companies are investing a disproportionately large amount of annual revenue in research and development (R&D), according to GlobalData��s Company Financials database.